Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000951 · ClinicalTrials.gov registry record · Phase 4
A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush
A Phase 4 study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- Phase 4
- Development phase
- 948
- Enrollment target
NCT00000951 is a Phase 4 study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 948 participants.
The verdict
NCT00000951, a Phase 4 study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 948 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether it is better to treat patients with fluconazole on a continuous basis to prevent thrush (yeast infection in the mouth) from coming back or to wait and treat each episode of thrush. Fluconazole is one of the most commonly prescribed drugs to treat thrush and other yeast infections. However, the number of patients with fluconazole-resistant thrush is increasing, and it is not known whether continuous or intermittent use of fluconazole leads to greater resistance. Therefore, it is important to determine the most effective treatment strategy.
Interventions
- DRUG Fluconazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 948 participants |
| Est. Completion | 2002-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000951
The ClinicalTrials.gov registry entry for NCT00000951 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 948 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluconazole is the first listed.
NCT00000951 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000951 about?
NCT00000951 is a clinical study titled "A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush". The purpose of this study is to determine whether it is better to treat patients with fluconazole on a continuous basis to prevent thrush (yeast infection in the mouth) from coming back or to wait and treat each episode of thrush. Fluconazole is one of the most commonly prescribed drugs to treat th...
What is the current status of trial NCT00000951?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 948 participants. Estimated completion is 2002-05.
What interventions are being tested in trial NCT00000951?
The interventions under investigation include: Fluconazole (DRUG).
Who is sponsoring clinical trial NCT00000951?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.